Alvotech: Initiating With Hold Rating On FDA CRL AVT05 And Reduced EBITDA Guidance (ALVO)
This article was written byFollowTerry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his...
CRL
Capricor Therapeutics: Buying Opportunity Following FDA’s CRL (CAPR)
This article was written byFollowBackground: Physician involved in clinical research. Investment style: Clinical-stage biotech stocks, long only, both long-term ideas and event-driven...
